5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP)

被引：56

作者：

VICKERS, PJ ^{[1
]}

机构：

[1] MERCK FROSST CTR THERAPEUT RES,DEPT BIOCHEM & MOLEC BIOL,MONTREAL,PQ H9R 4P8,CANADA

来源：

JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING | 1995年 / 12卷 / 2-3期

关键词：

LEUKOTRIENE; 5-LIPOXYGENASE; FLAP; MK-886; MK-591;

D O I：

10.1016/0929-7855(95)00018-L

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：185 / 194

页数：10

共 46 条

[11] REQUIREMENT OF A 5-LIPOXYGENASE-ACTIVATING PROTEIN FOR LEUKOTRIENE SYNTHESIS [J].

DIXON, RAF ;

DIEHL, RE ;

OPAS, E ;

RANDS, E ;

VICKERS, PJ ;

EVANS, JF ;

GILLARD, JW ;

MILLER, DK .

NATURE, 1990, 343 (6255) :282-284

[12]

EVANS JF, 1991, MOL PHARMACOL, V40, P22

[13]

FORDHUTCHINSON AW, 1989, LEUKOTRIENES LIPOXYG, P405

[14] L-663,536 (MK-886) (3-[1-(4-CHLOROBENZYL)-3-T-BUTYL-THIO-5-ISOPROPYLINDOL-2-YL]-2,2-DIMETHYLPROPANOIC ACID), A NOVEL, ORALLY ACTIVE LEUKOTRIENE BIOSYNTHESIS INHIBITOR [J].

GILLARD, J ;

FORDHUTCHINSON, AW ;

CHAN, C ;

CHARLESON, S ;

DENIS, D ;

FOSTER, A ;

FORTIN, R ;

LEGER, S ;

MCFARLANE, CS ;

MORTON, H ;

PIECHUTA, H ;

RIENDEAU, D ;

ROUZER, CA ;

ROKACH, J ;

YOUNG, R ;

MACINTYRE, DE ;

PETERSON, L ;

BACH, T ;

EIERMANN, G ;

HOPPLE, S ;

HUMES, J ;

HUPE, L ;

LUELL, S ;

METZGER, J ;

MEURER, R ;

MILLER, DK ;

OPAS, E ;

PACHOLOK, S .

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1989, 67 (05) :456-464

[15] MODE OF ACTION OF THE NEW SELECTIVE LEUKOTRIENE SYNTHESIS INHIBITOR BAY X-1005 ((R)-2-[4-(QUINOLIN-2-YL-METHOXY)PHENYL]-2-CYCLOPENTYL ACETIC-ACID) AND STRUCTURALLY RELATED-COMPOUNDS [J].

HATZELMANN, A ;

FRUCHTMANN, R ;

MOHRS, KH ;

RADDATZ, S ;

MULLERPEDDINGHAUS, R .

BIOCHEMICAL PHARMACOLOGY, 1993, 45 (01) :101-111

[16]

HILL E, 1992, J BIOL CHEM, V267, P22048

[17]

JONES TR, 1989, LEUKOTRIENES LIPOXYG, P309

[18]

KARGMAN S, 1991, J BIOL CHEM, V266, P23745

[19]

KARGMAN S, 1993, J LIPID MEDIATOR, V7, P31

[20]

KENNEDY BP, 1991, J BIOL CHEM, V266, P8511

← 1 2 3 4 5 →